» Articles » PMID: 38466970

Incidence and Health Care Burden of Uterine Fibroids Among Female Service Members in the Active Component of the U.S. Armed Forces, 2011-2022

Overview
Journal MSMR
Date 2024 Mar 11
PMID 38466970
Authors
Affiliations
Soon will be listed here.
Abstract

Uterine fibroids are the most common benign tumors of the uterus among women of reproductive age, disproportionally affecting non-Hispanic Black women compared to other races and ethnicities. This report is an update of a 2011 MSMR report that examined uterine fibroids among female active component service members in the U.S. Armed Forces from 2001 to 2010. Incident uterine fibroids were identified for this report from inpatient and outpatient medical encounter data from 2011 to 2022. Health care burden was estimated utilizing uterine fibroid-related inpatient and outpatient diagnostic and procedure codes. Crude incidence rates and incidence rate ratios were calculated to compare rate differences between subpopulations. A total of 16,046 new uterine fibroid cases were identified, with an incidence rate of 63.5 cases per 10,000 person-years (95% confidence interval: 62.5-64.5). The highest incidence rates were observed among service women 40 years and older, non-Hispanic Black women, and those who served in the Army. Health care burden analysis showed that, even with increases in medical encounters and individuals affected, the numbers of hospital bed days declined over time. The decline in uterine fibroid-related hospital bed days could be attributed to early diagnoses and minimally-invasive treatments. Continued promotion of uterine fibroid awareness can potentially help further reduce uterine fibroid-related impacts on military readiness.

Citing Articles

Postoperative symptom changes following uterine artery embolization for uterine fibroid based on FIGO classification.

Nozaki Y, Takeuchi S, Arai M, Kuwatsuru Y, Toei H, Okada S CVIR Endovasc. 2025; 8(1):9.

PMID: 39878921 PMC: 11780029. DOI: 10.1186/s42155-025-00520-7.

References
1.
Chang C, OBrien K, Keil A, Gaston S, Jackson C, Sandler D . Use of Straighteners and Other Hair Products and Incident Uterine Cancer. J Natl Cancer Inst. 2022; 114(12):1636-1645. PMC: 9949582. DOI: 10.1093/jnci/djac165. View

2.
Huang D, Magaoay B, Rosen M, Cedars M . Presence of Fibroids on Transvaginal Ultrasonography in a Community-Based, Diverse Cohort of 996 Reproductive-Age Female Participants. JAMA Netw Open. 2023; 6(5):e2312701. PMC: 10173016. DOI: 10.1001/jamanetworkopen.2023.12701. View

3.
. Uterine fibroids, active component females, U.S. Armed Forces, 2001-2010. MSMR. 2012; 18(12):10-3. View

4.
Paul E, Grey J, Carpenter T, Madaj Z, Lau K, Givan S . Transcriptome and DNA methylome analyses reveal underlying mechanisms for the racial disparity in uterine fibroids. JCI Insight. 2022; 7(20). PMC: 9714787. DOI: 10.1172/jci.insight.160274. View

5.
Bourne T, Leonardi M, Kyriacou C, Al-Memar M, Landolfo C, Cibula D . ISUOG Consensus Statement on rationalization of gynecological ultrasound services in context of SARS-CoV-2. Ultrasound Obstet Gynecol. 2020; 55(6):879-885. PMC: 7262398. DOI: 10.1002/uog.22047. View